When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - Halozyme earns $10M milestone from J&J under Enhanze license
Johnson & Johnson
Halozyme Therapeutics (NASDAQ:HALO) will receive a $10M milestone payment from Johnson & Johnson (NYSE:JNJ) unit Janssen Biotech triggered by the first commercial sale of subcutaneous formulation of DARZALEX (daratumumab) in the European Union.
More news on: Halozyme Therapeutics, Inc., Johnson & Johnson, Healthcare stocks news, Stocks on the move,